Human Molecular Genetics, 2002, Vol. 11, No. 17 1997-2004
© 2002 Oxford University Press
A missense mutation disrupting a dibasic prohormone processing site in pro-opiomelanocortin (POMC) increases susceptibility to early-onset obesity through a novel molecular mechanism



1University Departments of Medicine and Clinical Biochemistry, Addenbrooke's Hospital, Cambridge CB2 2QQ, UK, 2School of Biological Sciences and Faculty of Medicine, Stopford Building, University of Manchester, Manchester M13 9PT, UK and AstraZeneca, Mereside, Alderley Park, Cheshire SK10 4TG, UK, 3Laboratory for Molecular Oncology, Department for Human Genetics, University of Leuven and Flanders Interuniversity Institute for Biotechnology, Herestraat 49, B-3000 Leuven, Belgium, 4Institute of BiologyCNRS 8090, Pasteur Institute of Lille, CHRU of Lille, France, 5Institute of Public Health, Cambridge, UK and 6Barts and The London Genome Centre, Queen Mary's, University of London, UK
Received April 10, 2002; Accepted June 12, 2002
The functional loss of both alleles of the human pro-opiomelanocortin (POMC) gene leads to a very rare syndrome of hypoadrenalism, red hair and early-onset obesity. In order to examine whether more subtle genetic variants in POMC might contribute to early-onset obesity, the coding region of the gene was sequenced in 262 Caucasian subjects with a history of severe obesity from childhood. Two children were found to be heterozygous for a missense mutation, R236G, which disrupts the dibasic cleavage site between ß melanocyte-stimulating hormone (ß-MSH) and ß-endorphin. ß-TC3 cells transfected with the mutant POMC cDNA produced a mutant ß-MSH/ß-endorphin fusion protein. This fusion protein bound to the human melanocortin-4 receptor (hMC4R) with an affinity similar to its natural ligands, but had a markedly reduced ability to activate the receptor. This variant co-segregated with early-onset obesity over three generations in one family and was absent in 412 normal weight UK Caucasian controls. Combining the results in UK Caucasians with a new casecontrol study in French subjects and three previously published reports, mutations disrupting this processing site were present in 0.88% of subjects with early-onset obesity and 0.22% of normal-weight controls. These results suggest that the R236G mutation may confer an inherited susceptibility to obesity through the production of an aberrant fusion protein that has the capacity to interfere with central melanocortin signalling.
* To whom correspondence should be addressed at: University Departments of Medicine and Clinical Biochemistry, Box 157, Addenbrooke's Hospital, Cambridge CB2 2QR, UK. Tel: +44 1223336855; Fax: +44 1223330598; Email: sorahill{at}hgmp.mrc.ac.uk
The authors wish it to be known that, in their opinion, the first three authors should be regarded as joint First Authors.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
K. Clement, B. Dubern, M. Mencarelli, P. Czernichow, S. Ito, K. Wakamatsu, G. S. Barsh, C. Vaisse, and J. Leger Unexpected Endocrine Features and Normal Pigmentation in a Young Adult Patient Carrying a Novel Homozygous Mutation in the POMC Gene J. Clin. Endocrinol. Metab., December 1, 2008; 93(12): 4955 - 4962. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. M. Creemers, Y. S. Lee, R. L. Oliver, M. Bahceci, A. Tuzcu, D. Gokalp, J. Keogh, S. Herber, A. White, S. O'Rahilly, et al. Mutations in the Amino-Terminal Region of Proopiomelanocortin (POMC) in Patients with Early-Onset Obesity Impair POMC Sorting to the Regulated Secretory Pathway J. Clin. Endocrinol. Metab., November 1, 2008; 93(11): 4494 - 4499. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Sharma, W. Bottje, and R. Okimoto Polymorphisms in Uncoupling Protein, Melanocortin 3 Receptor, Melanocortin 4 Receptor, and Pro-Opiomelanocortin Genes and Association with Production Traits in a Commercial Broiler Line Poult. Sci., October 1, 2008; 87(10): 2073 - 2086. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Seng Lee, L. Kok Seng Poh, B. Lay Kee Kek, and K. Yin Loke The Role of Melanocortin 3 Receptor Gene in Childhood Obesity Diabetes, October 1, 2007; 56(10): 2622 - 2630. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. A. Nillni Regulation of Prohormone Convertases in Hypothalamic Neurons: Implications for ProThyrotropin-Releasing Hormone and Proopiomelanocortin Endocrinology, September 1, 2007; 148(9): 4191 - 4200. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Stutzmann, V. Vatin, S. Cauchi, A. Morandi, B. Jouret, O. Landt, P. Tounian, C. Levy-Marchal, R. Buzzetti, L. Pinelli, et al. Non-synonymous polymorphisms in melanocortin-4 receptor protect against obesity: the two facets of a Janus obesity gene Hum. Mol. Genet., August 1, 2007; 16(15): 1837 - 1844. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. S. Farooqi and S. O'Rahilly Genetics of Obesity in Humans Endocr. Rev., December 1, 2006; 27(7): 710 - 718. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. S. Farooqi, S. Drop, A. Clements, J. M. Keogh, J. Biernacka, S. Lowenbein, B. G. Challis, and S. O'Rahilly Heterozygosity for a POMC-Null Mutation and Increased Obesity Risk in Humans Diabetes, September 1, 2006; 55(9): 2549 - 2553. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. O'Rahilly and I.S. Farooqi Genetics of obesity Phil Trans R Soc B, July 29, 2006; 361(1471): 1095 - 1105. [Abstract] [Full Text] [PDF] |
||||
![]() |
M Druce and S R Bloom The regulation of appetite Arch. Dis. Child., February 1, 2006; 91(2): 183 - 187. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. M. Hsiung, J. Hertel, X.-y. Zhang, D. P. Smith, D. L. Smiley, M. L. Heiman, D. D. Yang, S. Husain, J. P. Mayer, L. Zhang, et al. A Novel and Selective {beta}-Melanocyte-Stimulating Hormone-Derived Peptide Agonist for Melanocortin 4 Receptor Potently Decreased Food Intake and Body Weight Gain in Diet-Induced Obese Rats Endocrinology, December 1, 2005; 146(12): 5257 - 5266. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. G. Bell, D. Meyre, C. Samson, C. Boyle, C. Lecoeur, M. Tauber, B. Jouret, D. Jaquet, C. Levy-Marchal, M. A. Charles, et al. Association of Melanin-Concentrating Hormone Receptor 1 5' Polymorphism With Early-Onset Extreme Obesity Diabetes, October 1, 2005; 54(10): 3049 - 3055. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Baker, N. Gaukrodger, B. M. Mayosi, H. Imrie, M. Farrall, H. Watkins, J. M.C. Connell, P. J. Avery, and B. Keavney Association Between Common Polymorphisms of the Proopiomelanocortin Gene and Body Fat Distribution: A Family Study Diabetes, August 1, 2005; 54(8): 2492 - 2496. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Buono, F. Pasanisi, C. Nardelli, L. Ieno, S. Capone, R. Liguori, C. Finelli, G. Oriani, F. Contaldo, and L. Sacchetti Six Novel Mutations in the Proopiomelanocortin and Melanocortin Receptor 4 Genes in Severely Obese Adults Living in Southern Italy Clin. Chem., August 1, 2005; 51(8): 1358 - 1364. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Mizuno, I-W. Shu, H. Makimura, and C. Mobbs Obesity Over the Life Course Sci. Aging Knowl. Environ., June 16, 2004; 2004(24): re4 - re4. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. P. Coll, I. S. Farooqi, B. G. Challis, G. S. H. Yeo, and S. O'Rahilly Proopiomelanocortin and Energy Balance: Insights from Human and Murine Genetics J. Clin. Endocrinol. Metab., June 1, 2004; 89(6): 2557 - 2562. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Jing, E. A. Nillni, V. C. Sanchez, R. C. Stuart, and D. J. Good Deletion of the Nhlh2 Transcription Factor Decreases the Levels of the Anorexigenic Peptides {alpha} Melanocyte-Stimulating Hormone and Thyrotropin-Releasing Hormone and Implicates Prohormone Convertases I and II in Obesity Endocrinology, April 1, 2004; 145(4): 1503 - 1513. [Abstract] [Full Text] [PDF] |
||||
![]() |
I.S. Farooqi and S. O'Rahilly Monogenic Human Obesity Syndromes Recent Prog. Horm. Res., January 1, 2004; 59(1): 409 - 424. [Abstract] [Full Text] |
||||
![]() |
H. Krude, H. Biebermann, D. Schnabel, M. Z. Tansek, P. Theunissen, P. E. Mullis, and A. Gruters Obesity Due to Proopiomelanocortin Deficiency: Three New Cases and Treatment Trials with Thyroid Hormone and ACTH4-10 J. Clin. Endocrinol. Metab., October 1, 2003; 88(10): 4633 - 4640. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. O'Rahilly, I. S. Farooqi, G. S. H. Yeo, and B. G. Challis Minireview: Human Obesity--Lessons from Monogenic Disorders Endocrinology, September 1, 2003; 144(9): 3757 - 3764. [Abstract] [Full Text] [PDF] |
||||










